SCHEMBL15909129

SCHEMBL15909129

C[C@@]1(NCc2cccc(F)c2)CC[C@@H]2CN(c3cccc(C(F)(F)F)n3)C[C@@H]21

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 3/20 0.45
TRPV1 Q8NER1 2/20 0.39
CXCR3 P49682 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
ACACB O00763 6/20 0.37
GRM4 Q14833 1/20 0.34
FFAR1 O14842 1/20 0.34
HTR1A P08908 2/20 0.34
DPP4 P27487 1/20 0.34
DPP9 Q86TI2 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
DRD2 P14416 2/20 0.33
DRD3 P35462 2/20 0.33
DRD4 P21917 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15908903 1.00 GRIN2B (0.45) GRIN2BTRPV1CXCR3HRH4ACACB
SCHEMBL15908996 0.91 GRIN2B (0.49) GRIN2BCXCR3ACACBFFAR1HTR1A
SCHEMBL15908921 0.91 GRIN2B (0.49) GRIN2BCXCR3ACACBFFAR1HTR1A
SCHEMBL15908902 0.85 GRIN2B (0.47) GRIN2BCXCR3ACACBGRM4FFAR1
SCHEMBL15908910 0.85 GRIN2B (0.47) GRIN2BCXCR3ACACBGRM4FFAR1
SCHEMBL37525 0.80 GRIN2B (0.46) GRIN2BCXCR3ACACBGRM4HTR1A
SCHEMBL37651 0.80 GRIN2B (0.46) GRIN2BCXCR3ACACBGRM4HTR1A
SCHEMBL15909032 0.80 GRIN2B (0.46) GRIN2BCXCR3ACACBGRM4HTR1A
SCHEMBL15909116 0.79 GRIN2B (0.50) GRIN2BTRPV1CXCR3ACACBFFAR1
SCHEMBL15909114 0.77 ACACB (0.52) GRIN2BCXCR3ACACBHCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110294854-A1 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS ABBOTT LABORATORIES (US) 2011-12-01 US claimed
US-8796470-B2 Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators ABBVIE INC. (US) 2014-08-05 US disclosed
US-20110294854-A1 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS ABBOTT LABORATORIES (US) 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294854-A1 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS ORAI1, CACNA1E, RYR1 GRIN2B 183/4885TRPV1 19/4885CXCR3 2877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.